

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 5.59504355 |
| 2 | pyrimidine nucleobase catabolic process (GO:0006208) | 5.35111148 |
| 3 | muscle filament sliding (GO:0030049) | 5.10228521 |
| 4 | actin-myosin filament sliding (GO:0033275) | 5.10228521 |
| 5 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.03727909 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.74536833 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.73764822 |
| 8 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.64684558 |
| 9 | regulation of skeletal muscle contraction (GO:0014819) | 4.61490083 |
| 10 | vocalization behavior (GO:0071625) | 4.59861527 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.48078935 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.44409511 |
| 13 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.33043105 |
| 14 | locomotory exploration behavior (GO:0035641) | 4.24918203 |
| 15 | response to inactivity (GO:0014854) | 4.24633937 |
| 16 | synaptic vesicle exocytosis (GO:0016079) | 4.22770768 |
| 17 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.21760583 |
| 18 | protein localization to synapse (GO:0035418) | 4.16104709 |
| 19 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.11733799 |
| 20 | skeletal muscle contraction (GO:0003009) | 4.09484119 |
| 21 | nucleobase catabolic process (GO:0046113) | 4.07150143 |
| 22 | retinal cone cell development (GO:0046549) | 4.01691133 |
| 23 | actin-mediated cell contraction (GO:0070252) | 4.00323839 |
| 24 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.95213023 |
| 25 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.91372885 |
| 26 | rhodopsin mediated signaling pathway (GO:0016056) | 3.84953669 |
| 27 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.79347269 |
| 28 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.77179803 |
| 29 | glutamate secretion (GO:0014047) | 3.76314773 |
| 30 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.72128605 |
| 31 | myofibril assembly (GO:0030239) | 3.67339715 |
| 32 | neurotransmitter secretion (GO:0007269) | 3.66042015 |
| 33 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.62430931 |
| 34 | dendritic spine morphogenesis (GO:0060997) | 3.61005364 |
| 35 | regulation of relaxation of muscle (GO:1901077) | 3.60498184 |
| 36 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.59311893 |
| 37 | regulation of synaptic vesicle transport (GO:1902803) | 3.58762308 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 3.55729611 |
| 39 | gamma-aminobutyric acid transport (GO:0015812) | 3.53874604 |
| 40 | transmission of nerve impulse (GO:0019226) | 3.52369926 |
| 41 | nerve growth factor signaling pathway (GO:0038180) | 3.50880169 |
| 42 | synaptic transmission, glutamatergic (GO:0035249) | 3.49609057 |
| 43 | axon ensheathment in central nervous system (GO:0032291) | 3.48060490 |
| 44 | central nervous system myelination (GO:0022010) | 3.48060490 |
| 45 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.47239779 |
| 46 | layer formation in cerebral cortex (GO:0021819) | 3.46743429 |
| 47 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.46202684 |
| 48 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.45422083 |
| 49 | membrane hyperpolarization (GO:0060081) | 3.42721601 |
| 50 | glutamate receptor signaling pathway (GO:0007215) | 3.37467534 |
| 51 | regulation of female receptivity (GO:0045924) | 3.36583522 |
| 52 | cellular potassium ion homeostasis (GO:0030007) | 3.34305357 |
| 53 | exploration behavior (GO:0035640) | 3.33677061 |
| 54 | regulation of synapse structural plasticity (GO:0051823) | 3.32515884 |
| 55 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.32334466 |
| 56 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.31605936 |
| 57 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.31359044 |
| 58 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.29271639 |
| 59 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.28514504 |
| 60 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.28514504 |
| 61 | striated muscle contraction (GO:0006941) | 3.27473390 |
| 62 | positive regulation of membrane potential (GO:0045838) | 3.26597037 |
| 63 | neurotransmitter transport (GO:0006836) | 3.25869851 |
| 64 | presynaptic membrane assembly (GO:0097105) | 3.25212992 |
| 65 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.25057532 |
| 66 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.22345584 |
| 67 | regulation of postsynaptic membrane potential (GO:0060078) | 3.21528264 |
| 68 | neuron recognition (GO:0008038) | 3.21259273 |
| 69 | skeletal muscle fiber development (GO:0048741) | 3.20524969 |
| 70 | positive regulation of synapse maturation (GO:0090129) | 3.19811590 |
| 71 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.18550850 |
| 72 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.18107015 |
| 73 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.15545716 |
| 74 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.14969395 |
| 75 | adult walking behavior (GO:0007628) | 3.13342166 |
| 76 | presynaptic membrane organization (GO:0097090) | 3.12381888 |
| 77 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.12260150 |
| 78 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.10321649 |
| 79 | establishment of mitochondrion localization (GO:0051654) | 3.09678429 |
| 80 | regulation of neurotransmitter secretion (GO:0046928) | 3.08455865 |
| 81 | response to pheromone (GO:0019236) | 3.08029175 |
| 82 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.07799857 |
| 83 | neuromuscular process controlling posture (GO:0050884) | 3.07451134 |
| 84 | long-term memory (GO:0007616) | 3.05810127 |
| 85 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.05164692 |
| 86 | cardiac myofibril assembly (GO:0055003) | 3.04610399 |
| 87 | dendrite morphogenesis (GO:0048813) | 3.02861084 |
| 88 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.02759367 |
| 89 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.01883980 |
| 90 | startle response (GO:0001964) | 3.01073250 |
| 91 | prepulse inhibition (GO:0060134) | 2.99441676 |
| 92 | cerebellar granule cell differentiation (GO:0021707) | 2.99238515 |
| 93 | myotube cell development (GO:0014904) | 2.98983294 |
| 94 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.98055970 |
| 95 | detection of light stimulus involved in visual perception (GO:0050908) | 2.98055970 |
| 96 | actin filament-based movement (GO:0030048) | 2.97484306 |
| 97 | membrane depolarization during action potential (GO:0086010) | 2.96964461 |
| 98 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.95492405 |
| 99 | response to histamine (GO:0034776) | 2.94667106 |
| 100 | axonal fasciculation (GO:0007413) | 2.93989252 |
| 101 | postsynaptic membrane organization (GO:0001941) | 2.92719444 |
| 102 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.92472351 |
| 103 | female mating behavior (GO:0060180) | 2.91786435 |
| 104 | neuronal ion channel clustering (GO:0045161) | 2.90992664 |
| 105 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.90659452 |
| 106 | myotube differentiation (GO:0014902) | 2.90558311 |
| 107 | regulation of neurotransmitter transport (GO:0051588) | 2.90183500 |
| 108 | striatum development (GO:0021756) | 2.89076265 |
| 109 | regulation of neurotransmitter levels (GO:0001505) | 2.88929662 |
| 110 | positive regulation of amino acid transport (GO:0051957) | 2.87212415 |
| 111 | behavioral response to cocaine (GO:0048148) | 2.86997964 |
| 112 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.86848797 |
| 113 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.86643220 |
| 114 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.86643220 |
| 115 | membrane depolarization (GO:0051899) | 2.85837180 |
| 116 | regulation of vesicle fusion (GO:0031338) | 2.85649114 |
| 117 | neuromuscular synaptic transmission (GO:0007274) | 2.85471544 |
| 118 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.85033995 |
| 119 | photoreceptor cell differentiation (GO:0046530) | 2.84425790 |
| 120 | eye photoreceptor cell differentiation (GO:0001754) | 2.84425790 |
| 121 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 2.84282420 |
| 122 | mitochondrion transport along microtubule (GO:0047497) | 2.84282420 |
| 123 | photoreceptor cell development (GO:0042461) | 2.83591096 |
| 124 | activation of protein kinase A activity (GO:0034199) | 2.81637483 |
| 125 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.81489272 |
| 126 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.81283409 |
| 127 | glycine transport (GO:0015816) | 2.80930093 |
| 128 | positive regulation of neurotransmitter transport (GO:0051590) | 2.78826408 |
| 129 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.78760571 |
| 130 | synaptic vesicle endocytosis (GO:0048488) | 2.78465900 |
| 131 | regulation of membrane repolarization (GO:0060306) | 2.78342918 |
| 132 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.78218868 |
| 133 | neuromuscular process controlling balance (GO:0050885) | 2.77814234 |
| 134 | sodium ion export (GO:0071436) | 2.76602696 |
| 135 | eye photoreceptor cell development (GO:0042462) | 2.76368026 |
| 136 | auditory behavior (GO:0031223) | 2.76093540 |
| 137 | synapse organization (GO:0050808) | 2.76030911 |
| 138 | regulation of cell communication by electrical coupling (GO:0010649) | 2.75827135 |
| 139 | long-term synaptic potentiation (GO:0060291) | 2.74942684 |
| 140 | synapse assembly (GO:0007416) | 2.74818105 |
| 141 | positive regulation of synapse assembly (GO:0051965) | 2.74115876 |
| 142 | muscle fiber development (GO:0048747) | 2.73715636 |
| 143 | negative regulation of muscle contraction (GO:0045932) | 2.72995128 |
| 144 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.72961361 |
| 145 | response to parathyroid hormone (GO:0071107) | 2.72599935 |
| 146 | response to auditory stimulus (GO:0010996) | 2.70052204 |
| 147 | cell migration in hindbrain (GO:0021535) | 2.69964478 |
| 148 | positive regulation of dendritic spine development (GO:0060999) | 2.69155782 |
| 149 | righting reflex (GO:0060013) | 2.69059258 |
| 150 | regulation of actin filament-based movement (GO:1903115) | 2.67724172 |
| 151 | suckling behavior (GO:0001967) | 2.66459400 |
| 152 | regulation of glutamate secretion (GO:0014048) | 2.64418057 |
| 153 | behavioral response to nicotine (GO:0035095) | 2.62252861 |
| 154 | regulation of dendrite morphogenesis (GO:0048814) | 2.61816520 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.71855180 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.68036613 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.94193005 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.87499161 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.84447499 |
| 6 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62245650 |
| 7 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62245650 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.54982947 |
| 9 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.51265037 |
| 10 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.46162784 |
| 11 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41144926 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.40762594 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.38881231 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36279919 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.35486193 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.33491859 |
| 17 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.26736258 |
| 18 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.23787305 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.21702639 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.20291464 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.09993567 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.06422491 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.00623330 |
| 24 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.93829731 |
| 25 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.82823178 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.79158089 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74427411 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.74126611 |
| 29 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.70038211 |
| 30 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.67776099 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.57248564 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57159203 |
| 33 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55692001 |
| 34 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54629760 |
| 35 | * CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.52864889 |
| 36 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.50983733 |
| 37 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.47903256 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.46999440 |
| 39 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.46564589 |
| 40 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46251339 |
| 41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.45071321 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.43031165 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42160013 |
| 44 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.41273650 |
| 45 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.40996766 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39366336 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.38138445 |
| 48 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37347661 |
| 49 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.37229220 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36421845 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.35754435 |
| 52 | P300_19829295_ChIP-Seq_ESCs_Human | 1.35602491 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.31288758 |
| 54 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.30409091 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29977297 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28284300 |
| 57 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.26816582 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26370317 |
| 59 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.24843329 |
| 60 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23156520 |
| 61 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.23089649 |
| 62 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.23005706 |
| 63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22496074 |
| 64 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.20559404 |
| 65 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19592066 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16100058 |
| 67 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.16032401 |
| 68 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13507370 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.12802175 |
| 70 | AR_25329375_ChIP-Seq_VCAP_Human | 1.12571882 |
| 71 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.11323462 |
| 72 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.09061742 |
| 73 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.08875766 |
| 74 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.08504961 |
| 75 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.07452571 |
| 76 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07140217 |
| 77 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07049589 |
| 78 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.06935509 |
| 79 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.06533241 |
| 80 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.05390685 |
| 81 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05225234 |
| 82 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.04919934 |
| 83 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04433264 |
| 84 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.04425780 |
| 85 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.03864772 |
| 86 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.03225590 |
| 87 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02884351 |
| 88 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.01394169 |
| 89 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.01311599 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01166304 |
| 91 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01131268 |
| 92 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00749817 |
| 93 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00517408 |
| 94 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99858015 |
| 95 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98531836 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97770934 |
| 97 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97770934 |
| 98 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95507928 |
| 99 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.94709751 |
| 100 | KDM2B_26808549_Chip-Seq_K562_Human | 0.94368441 |
| 101 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.94145688 |
| 102 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.93821630 |
| 103 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.93652987 |
| 104 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.93172972 |
| 105 | * CBP_20019798_ChIP-Seq_JUKART_Human | 0.93172972 |
| 106 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.92779716 |
| 107 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92454279 |
| 108 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91226023 |
| 109 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.91226023 |
| 110 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90961265 |
| 111 | VDR_22108803_ChIP-Seq_LS180_Human | 0.90899614 |
| 112 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90828475 |
| 113 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90385166 |
| 114 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.90222942 |
| 115 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89654728 |
| 116 | KDM2B_26808549_Chip-Seq_REH_Human | 0.89331609 |
| 117 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.89293838 |
| 118 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.88725750 |
| 119 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88598526 |
| 120 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88384290 |
| 121 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88180238 |
| 122 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86610392 |
| 123 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.85983184 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.63564998 |
| 2 | MP0003880_abnormal_central_pattern | 4.11461295 |
| 3 | MP0004270_analgesia | 3.55775928 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 3.29940040 |
| 5 | MP0005551_abnormal_eye_electrophysiolog | 3.02953228 |
| 6 | MP0005423_abnormal_somatic_nervous | 3.00818995 |
| 7 | MP0009046_muscle_twitch | 2.89014448 |
| 8 | MP0009745_abnormal_behavioral_response | 2.78940595 |
| 9 | MP0002064_seizures | 2.74046113 |
| 10 | MP0004145_abnormal_muscle_electrophysio | 2.64033324 |
| 11 | MP0002063_abnormal_learning/memory/cond | 2.60143732 |
| 12 | MP0001486_abnormal_startle_reflex | 2.53547847 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.44484655 |
| 14 | MP0002272_abnormal_nervous_system | 2.43130766 |
| 15 | MP0002822_catalepsy | 2.38825889 |
| 16 | MP0000751_myopathy | 2.30371301 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.30223114 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.30174404 |
| 19 | MP0004510_myositis | 2.07880332 |
| 20 | MP0003646_muscle_fatigue | 1.94057381 |
| 21 | MP0006072_abnormal_retinal_apoptosis | 1.90279026 |
| 22 | MP0004084_abnormal_cardiac_muscle | 1.89995713 |
| 23 | MP0002067_abnormal_sensory_capabilities | 1.84063565 |
| 24 | MP0005253_abnormal_eye_physiology | 1.83374745 |
| 25 | MP0009780_abnormal_chondrocyte_physiolo | 1.83032139 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.78110837 |
| 27 | MP0001440_abnormal_grooming_behavior | 1.77366076 |
| 28 | MP0006276_abnormal_autonomic_nervous | 1.75946427 |
| 29 | MP0001529_abnormal_vocalization | 1.75889236 |
| 30 | MP0008569_lethality_at_weaning | 1.73444972 |
| 31 | MP0004142_abnormal_muscle_tone | 1.69336630 |
| 32 | MP0000778_abnormal_nervous_system | 1.66111558 |
| 33 | MP0002184_abnormal_innervation | 1.64046102 |
| 34 | MP0001984_abnormal_olfaction | 1.62728436 |
| 35 | MP0001970_abnormal_pain_threshold | 1.61646200 |
| 36 | MP0002735_abnormal_chemical_nociception | 1.59439314 |
| 37 | * MP0005386_behavior/neurological_phenoty | 1.57052610 |
| 38 | * MP0004924_abnormal_behavior | 1.57052610 |
| 39 | MP0002733_abnormal_thermal_nociception | 1.56873614 |
| 40 | MP0003011_delayed_dark_adaptation | 1.55856740 |
| 41 | MP0002909_abnormal_adrenal_gland | 1.54670909 |
| 42 | MP0002882_abnormal_neuron_morphology | 1.54184252 |
| 43 | MP0004885_abnormal_endolymph | 1.54028269 |
| 44 | MP0002736_abnormal_nociception_after | 1.52954987 |
| 45 | MP0003122_maternal_imprinting | 1.52327812 |
| 46 | * MP0002229_neurodegeneration | 1.50224169 |
| 47 | * MP0004087_abnormal_muscle_fiber | 1.50201266 |
| 48 | MP0005646_abnormal_pituitary_gland | 1.47788623 |
| 49 | MP0000920_abnormal_myelination | 1.45364190 |
| 50 | MP0002557_abnormal_social/conspecific_i | 1.45004589 |
| 51 | MP0000955_abnormal_spinal_cord | 1.44267079 |
| 52 | MP0003329_amyloid_beta_deposits | 1.41332460 |
| 53 | MP0000747_muscle_weakness | 1.40334786 |
| 54 | MP0005464_abnormal_platelet_physiology | 1.40152731 |
| 55 | MP0001502_abnormal_circadian_rhythm | 1.39261557 |
| 56 | MP0002090_abnormal_vision | 1.39246235 |
| 57 | MP0005645_abnormal_hypothalamus_physiol | 1.39166820 |
| 58 | MP0001299_abnormal_eye_distance/ | 1.38376275 |
| 59 | MP0004742_abnormal_vestibular_system | 1.36066326 |
| 60 | * MP0002066_abnormal_motor_capabilities/c | 1.35857669 |
| 61 | MP0001905_abnormal_dopamine_level | 1.32262149 |
| 62 | MP0000749_muscle_degeneration | 1.30117808 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.28224401 |
| 64 | MP0003950_abnormal_plasma_membrane | 1.24856279 |
| 65 | MP0003787_abnormal_imprinting | 1.22244106 |
| 66 | MP0002752_abnormal_somatic_nervous | 1.22040656 |
| 67 | MP0004233_abnormal_muscle_weight | 1.20623115 |
| 68 | MP0002638_abnormal_pupillary_reflex | 1.12481790 |
| 69 | MP0005195_abnormal_posterior_eye | 1.12193868 |
| 70 | MP0004134_abnormal_chest_morphology | 1.10673644 |
| 71 | MP0004036_abnormal_muscle_relaxation | 1.08894949 |
| 72 | MP0002269_muscular_atrophy | 1.07789371 |
| 73 | MP0003634_abnormal_glial_cell | 1.07252714 |
| 74 | MP0003633_abnormal_nervous_system | 1.02574638 |
| 75 | MP0001963_abnormal_hearing_physiology | 1.00432933 |
| 76 | MP0002972_abnormal_cardiac_muscle | 0.98326707 |
| 77 | MP0005535_abnormal_body_temperature | 0.98205581 |
| 78 | MP0000230_abnormal_systemic_arterial | 0.97938876 |
| 79 | MP0003183_abnormal_peptide_metabolism | 0.96563566 |
| 80 | MP0002152_abnormal_brain_morphology | 0.96328312 |
| 81 | MP0004484_altered_response_of | 0.96147315 |
| 82 | MP0002127_abnormal_cardiovascular_syste | 0.95922282 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 0.93064169 |
| 84 | MP0000750_abnormal_muscle_regeneration | 0.92360762 |
| 85 | MP0003631_nervous_system_phenotype | 0.92023456 |
| 86 | MP0003690_abnormal_glial_cell | 0.89286025 |
| 87 | MP0005620_abnormal_muscle_contractility | 0.88600829 |
| 88 | MP0004858_abnormal_nervous_system | 0.88112348 |
| 89 | MP0002108_abnormal_muscle_morphology | 0.87482783 |
| 90 | MP0000631_abnormal_neuroendocrine_gland | 0.87234446 |
| 91 | MP0003879_abnormal_hair_cell | 0.86680831 |
| 92 | MP0004215_abnormal_myocardial_fiber | 0.84390468 |
| 93 | * MP0000759_abnormal_skeletal_muscle | 0.82908512 |
| 94 | MP0000733_abnormal_muscle_development | 0.81812433 |
| 95 | MP0002106_abnormal_muscle_physiology | 0.81601827 |
| 96 | MP0005369_muscle_phenotype | 0.80804808 |
| 97 | MP0001188_hyperpigmentation | 0.80797274 |
| 98 | MP0004085_abnormal_heartbeat | 0.80019376 |
| 99 | MP0001177_atelectasis | 0.79236949 |
| 100 | MP0003632_abnormal_nervous_system | 0.78668822 |
| 101 | MP0008874_decreased_physiological_sensi | 0.76446838 |
| 102 | MP0005167_abnormal_blood-brain_barrier | 0.76279610 |
| 103 | MP0003283_abnormal_digestive_organ | 0.75849753 |
| 104 | MP0002069_abnormal_eating/drinking_beha | 0.74498585 |
| 105 | MP0009250_abnormal_appendicular_skeleto | 0.73805173 |
| 106 | MP0003137_abnormal_impulse_conducting | 0.73406027 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.70805956 |
| 108 | MP0010386_abnormal_urinary_bladder | 0.70435198 |
| 109 | MP0000013_abnormal_adipose_tissue | 0.68959855 |
| 110 | MP0005385_cardiovascular_system_phenoty | 0.68518005 |
| 111 | MP0001544_abnormal_cardiovascular_syste | 0.68518005 |
| 112 | MP0003045_fibrosis | 0.68510932 |
| 113 | MP0001943_abnormal_respiration | 0.67992428 |
| 114 | MP0004130_abnormal_muscle_cell | 0.67774147 |
| 115 | MP0008872_abnormal_physiological_respon | 0.65673343 |
| 116 | MP0005409_darkened_coat_color | 0.63904693 |
| 117 | MP0005394_taste/olfaction_phenotype | 0.63738944 |
| 118 | MP0005499_abnormal_olfactory_system | 0.63738944 |
| 119 | MP0010769_abnormal_survival | 0.62994850 |
| 120 | MP0001664_abnormal_digestion | 0.62136729 |
| 121 | MP0005503_abnormal_tendon_morphology | 0.60515953 |
| 122 | MP0008775_abnormal_heart_ventricle | 0.60271063 |
| 123 | MP0002971_abnormal_brown_adipose | 0.59811194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.28681587 |
| 2 | Congenital stationary night blindness (HP:0007642) | 4.75895672 |
| 3 | Myokymia (HP:0002411) | 4.70600610 |
| 4 | Vitreoretinal degeneration (HP:0000655) | 4.41956614 |
| 5 | Dyschromatopsia (HP:0007641) | 4.18327042 |
| 6 | Central scotoma (HP:0000603) | 3.94814654 |
| 7 | Epiphyseal dysplasia (HP:0002656) | 3.87517847 |
| 8 | Focal seizures (HP:0007359) | 3.79027415 |
| 9 | Abnormality of macular pigmentation (HP:0008002) | 3.78138184 |
| 10 | Myopathic facies (HP:0002058) | 3.58086519 |
| 11 | Hyporeflexia of lower limbs (HP:0002600) | 3.57100691 |
| 12 | Progressive cerebellar ataxia (HP:0002073) | 3.44459958 |
| 13 | Epileptic encephalopathy (HP:0200134) | 3.42646437 |
| 14 | Rimmed vacuoles (HP:0003805) | 3.41887565 |
| 15 | Visual hallucinations (HP:0002367) | 3.41843200 |
| 16 | EMG: myopathic abnormalities (HP:0003458) | 3.41019167 |
| 17 | Broad-based gait (HP:0002136) | 3.37498258 |
| 18 | Calcaneovalgus deformity (HP:0001848) | 3.35976349 |
| 19 | Irregular epiphyses (HP:0010582) | 3.35848095 |
| 20 | Hypoplastic ischia (HP:0003175) | 3.34263864 |
| 21 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.29293656 |
| 22 | Exercise-induced myalgia (HP:0003738) | 3.26188452 |
| 23 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.25423033 |
| 24 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.22846796 |
| 25 | Subaortic stenosis (HP:0001682) | 3.22846796 |
| 26 | Febrile seizures (HP:0002373) | 3.18200140 |
| 27 | Frequent falls (HP:0002359) | 3.14851619 |
| 28 | Papilledema (HP:0001085) | 3.13433643 |
| 29 | Atonic seizures (HP:0010819) | 3.11075327 |
| 30 | Scotoma (HP:0000575) | 3.09590772 |
| 31 | Bundle branch block (HP:0011710) | 3.07433922 |
| 32 | Myoglobinuria (HP:0002913) | 3.07206725 |
| 33 | Ankle clonus (HP:0011448) | 3.04760871 |
| 34 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.02282204 |
| 35 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.96704056 |
| 36 | Action tremor (HP:0002345) | 2.95343176 |
| 37 | Abnormality of the ischium (HP:0003174) | 2.95101762 |
| 38 | Absence seizures (HP:0002121) | 2.94632547 |
| 39 | Rhabdomyolysis (HP:0003201) | 2.87648429 |
| 40 | Deformed tarsal bones (HP:0008119) | 2.86923063 |
| 41 | Absent phalangeal crease (HP:0006109) | 2.82348315 |
| 42 | Round ear (HP:0100830) | 2.82139065 |
| 43 | Sudden death (HP:0001699) | 2.79449003 |
| 44 | Supranuclear gaze palsy (HP:0000605) | 2.77438721 |
| 45 | Small epiphyses (HP:0010585) | 2.75739934 |
| 46 | Generalized tonic-clonic seizures (HP:0002069) | 2.75455576 |
| 47 | Muscle fiber inclusion bodies (HP:0100299) | 2.73712280 |
| 48 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.70869325 |
| 49 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.69846389 |
| 50 | Areflexia of lower limbs (HP:0002522) | 2.69708209 |
| 51 | Abnormality of binocular vision (HP:0011514) | 2.67833869 |
| 52 | Diplopia (HP:0000651) | 2.67833869 |
| 53 | Ulnar deviation of the wrist (HP:0003049) | 2.67661858 |
| 54 | Abnormality of the corticospinal tract (HP:0002492) | 2.67194907 |
| 55 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.67099468 |
| 56 | Dysdiadochokinesis (HP:0002075) | 2.66964483 |
| 57 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.66963609 |
| 58 | EMG: neuropathic changes (HP:0003445) | 2.65953414 |
| 59 | Gaze-evoked nystagmus (HP:0000640) | 2.64733896 |
| 60 | Dialeptic seizures (HP:0011146) | 2.64385390 |
| 61 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.61889831 |
| 62 | Spastic gait (HP:0002064) | 2.54541360 |
| 63 | Urinary urgency (HP:0000012) | 2.53478652 |
| 64 | Nemaline bodies (HP:0003798) | 2.53290669 |
| 65 | Failure to thrive in infancy (HP:0001531) | 2.51726800 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.51501128 |
| 67 | Decreased central vision (HP:0007663) | 2.50092545 |
| 68 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.46739194 |
| 69 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.46739194 |
| 70 | Dysmetria (HP:0001310) | 2.46491760 |
| 71 | Truncal ataxia (HP:0002078) | 2.46264614 |
| 72 | Fetal akinesia sequence (HP:0001989) | 2.45233204 |
| 73 | Neck muscle weakness (HP:0000467) | 2.39976556 |
| 74 | Lower limb amyotrophy (HP:0007210) | 2.37348440 |
| 75 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.37040437 |
| 76 | Scanning speech (HP:0002168) | 2.34839834 |
| 77 | Abnormal finger flexion creases (HP:0006143) | 2.34742352 |
| 78 | Neurofibrillary tangles (HP:0002185) | 2.33403183 |
| 79 | Long clavicles (HP:0000890) | 2.30336882 |
| 80 | Hyperkalemia (HP:0002153) | 2.27062779 |
| 81 | Hyperventilation (HP:0002883) | 2.26712950 |
| 82 | Exercise-induced muscle cramps (HP:0003710) | 2.25741154 |
| 83 | Malignant hyperthermia (HP:0002047) | 2.25501310 |
| 84 | Calf muscle hypertrophy (HP:0008981) | 2.23109912 |
| 85 | Termporal pattern (HP:0011008) | 2.21336985 |
| 86 | Insidious onset (HP:0003587) | 2.21336985 |
| 87 | Anxiety (HP:0000739) | 2.19714267 |
| 88 | Genetic anticipation (HP:0003743) | 2.16998560 |
| 89 | Mutism (HP:0002300) | 2.16581188 |
| 90 | Generalized muscle weakness (HP:0003324) | 2.16172000 |
| 91 | Abolished electroretinogram (ERG) (HP:0000550) | 2.15633479 |
| 92 | Waddling gait (HP:0002515) | 2.15019857 |
| 93 | Poor eye contact (HP:0000817) | 2.14658606 |
| 94 | Type 1 muscle fiber predominance (HP:0003803) | 2.12880494 |
| 95 | Mild short stature (HP:0003502) | 2.12426481 |
| 96 | Pheochromocytoma (HP:0002666) | 2.11991641 |
| 97 | Depression (HP:0000716) | 2.11955915 |
| 98 | Heart block (HP:0012722) | 2.11543787 |
| 99 | Difficulty running (HP:0009046) | 2.10403716 |
| 100 | Distal lower limb amyotrophy (HP:0008944) | 2.10268663 |
| 101 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.09392069 |
| 102 | Intention tremor (HP:0002080) | 2.08077623 |
| 103 | Limb dystonia (HP:0002451) | 2.05707717 |
| 104 | Torticollis (HP:0000473) | 2.01579930 |
| 105 | Cupped ribs (HP:0000887) | 2.01435768 |
| 106 | Hemiparesis (HP:0001269) | 1.99577947 |
| 107 | Neonatal hypoglycemia (HP:0001998) | 1.98542859 |
| 108 | Hypothermia (HP:0002045) | 1.97482789 |
| 109 | Abnormal social behavior (HP:0012433) | 1.97332630 |
| 110 | Impaired social interactions (HP:0000735) | 1.97332630 |
| 111 | Attenuation of retinal blood vessels (HP:0007843) | 1.97128539 |
| 112 | Choroideremia (HP:0001139) | 1.96879301 |
| 113 | Abnormal eating behavior (HP:0100738) | 1.96202376 |
| 114 | Abnormality of the calf musculature (HP:0001430) | 1.94903811 |
| 115 | Myotonia (HP:0002486) | 1.94800859 |
| 116 | Postural instability (HP:0002172) | 1.93220686 |
| 117 | Lower limb muscle weakness (HP:0007340) | 1.92194529 |
| 118 | Excessive salivation (HP:0003781) | 1.92089685 |
| 119 | Drooling (HP:0002307) | 1.92089685 |
| 120 | Severe visual impairment (HP:0001141) | 1.88951666 |
| 121 | Distal arthrogryposis (HP:0005684) | 1.87249764 |
| 122 | Chorioretinal atrophy (HP:0000533) | 1.86913326 |
| 123 | Pigmentary retinal degeneration (HP:0001146) | 1.86440776 |
| 124 | Scapular winging (HP:0003691) | 1.86331034 |
| 125 | Menorrhagia (HP:0000132) | 1.85456721 |
| 126 | Pendular nystagmus (HP:0012043) | 1.84646679 |
| 127 | Increased mean platelet volume (HP:0011877) | 1.83301800 |
| 128 | Neuroendocrine neoplasm (HP:0100634) | 1.83051392 |
| 129 | Abnormal atrioventricular conduction (HP:0005150) | 1.82966437 |
| 130 | Abnormality of the pubic bones (HP:0003172) | 1.81494039 |
| 131 | Muscle fiber splitting (HP:0003555) | 1.80900340 |
| 132 | Progressive inability to walk (HP:0002505) | 1.80769176 |
| 133 | Asymmetric septal hypertrophy (HP:0001670) | 1.80483958 |
| 134 | Prolonged QT interval (HP:0001657) | 1.80293227 |
| 135 | Cerebral inclusion bodies (HP:0100314) | 1.79829153 |
| 136 | Gait imbalance (HP:0002141) | 1.79041190 |
| 137 | Delayed epiphyseal ossification (HP:0002663) | 1.76417512 |
| 138 | Relative macrocephaly (HP:0004482) | 1.75078747 |
| 139 | Increased variability in muscle fiber diameter (HP:0003557) | 1.74229996 |
| 140 | Photophobia (HP:0000613) | 1.73815347 |
| 141 | Limited hip movement (HP:0008800) | 1.73802110 |
| 142 | Slender build (HP:0001533) | 1.73315619 |
| 143 | Abnormality of the foot musculature (HP:0001436) | 1.71853935 |
| 144 | Polyphagia (HP:0002591) | 1.71572132 |
| 145 | Flat capital femoral epiphysis (HP:0003370) | 1.71398500 |
| 146 | Muscle stiffness (HP:0003552) | 1.71305452 |
| 147 | Weak cry (HP:0001612) | 1.69932778 |
| 148 | Facial diplegia (HP:0001349) | 1.69436889 |
| 149 | Abnormal platelet volume (HP:0011876) | 1.65614779 |
| 150 | Nonprogressive disorder (HP:0003680) | 1.63682877 |
| 151 | Akinesia (HP:0002304) | 1.63342299 |
| 152 | Petechiae (HP:0000967) | 1.63156191 |
| 153 | Bulbar palsy (HP:0001283) | 1.63136733 |
| 154 | Epileptiform EEG discharges (HP:0011182) | 1.62882738 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.53235007 |
| 2 | MARK1 | 3.24905828 |
| 3 | EPHA4 | 3.05528267 |
| 4 | MAP3K4 | 2.92193153 |
| 5 | MAP3K9 | 2.77387636 |
| 6 | PHKG2 | 2.36325203 |
| 7 | PHKG1 | 2.36325203 |
| 8 | PAK6 | 2.22579202 |
| 9 | PNCK | 2.20242321 |
| 10 | MAP2K7 | 2.19656968 |
| 11 | MINK1 | 1.99462903 |
| 12 | NTRK2 | 1.98655689 |
| 13 | TNIK | 1.90730891 |
| 14 | MAP2K4 | 1.88475854 |
| 15 | CASK | 1.87317403 |
| 16 | OXSR1 | 1.85057315 |
| 17 | STK39 | 1.81274516 |
| 18 | CDK19 | 1.81215742 |
| 19 | NTRK1 | 1.79553393 |
| 20 | PIK3CG | 1.75820600 |
| 21 | NME1 | 1.64000272 |
| 22 | DYRK2 | 1.56988546 |
| 23 | TTN | 1.55429387 |
| 24 | OBSCN | 1.53211013 |
| 25 | IRAK1 | 1.51718469 |
| 26 | DDR2 | 1.42990161 |
| 27 | PINK1 | 1.42649163 |
| 28 | CDK5 | 1.42320227 |
| 29 | CAMKK1 | 1.39964325 |
| 30 | KSR1 | 1.38348117 |
| 31 | DAPK2 | 1.34277934 |
| 32 | KSR2 | 1.32718524 |
| 33 | WNK1 | 1.32151802 |
| 34 | PRPF4B | 1.26903193 |
| 35 | MAPK13 | 1.26701715 |
| 36 | UHMK1 | 1.23022000 |
| 37 | CCNB1 | 1.19640783 |
| 38 | MOS | 1.18849340 |
| 39 | SGK494 | 1.18339985 |
| 40 | SGK223 | 1.18339985 |
| 41 | BCR | 1.17016827 |
| 42 | MAP3K12 | 1.14605703 |
| 43 | PRKD3 | 1.09465976 |
| 44 | PKN1 | 1.05324716 |
| 45 | GRK1 | 1.04697495 |
| 46 | CAMK1G | 1.04309012 |
| 47 | PLK2 | 1.04214944 |
| 48 | CAMK2A | 0.99968037 |
| 49 | YES1 | 0.98953488 |
| 50 | SIK2 | 0.98042487 |
| 51 | PRKCG | 0.96521928 |
| 52 | GRK5 | 0.96096002 |
| 53 | LIMK1 | 0.94463129 |
| 54 | CAMK2B | 0.94222252 |
| 55 | CAMKK2 | 0.92787729 |
| 56 | NEK6 | 0.90624011 |
| 57 | STK11 | 0.90352556 |
| 58 | CDK14 | 0.87075617 |
| 59 | PRKCH | 0.86599015 |
| 60 | CDK18 | 0.86370080 |
| 61 | CSNK1G2 | 0.86311125 |
| 62 | MUSK | 0.85845175 |
| 63 | CDK15 | 0.85178753 |
| 64 | CAMK2D | 0.83692079 |
| 65 | FES | 0.83477470 |
| 66 | MAPK12 | 0.82302939 |
| 67 | MARK2 | 0.81671753 |
| 68 | DYRK1A | 0.81637368 |
| 69 | MAP4K2 | 0.81058989 |
| 70 | INSRR | 0.79387852 |
| 71 | STK38 | 0.79171143 |
| 72 | WNK4 | 0.76562703 |
| 73 | SGK1 | 0.74412323 |
| 74 | CDK11A | 0.73424144 |
| 75 | PAK3 | 0.72606993 |
| 76 | CAMK2G | 0.72300083 |
| 77 | TYRO3 | 0.71871696 |
| 78 | SGK2 | 0.71791230 |
| 79 | CAMK1 | 0.70171178 |
| 80 | SYK | 0.69643565 |
| 81 | ROCK2 | 0.68139583 |
| 82 | MAP3K7 | 0.65199606 |
| 83 | ICK | 0.65032352 |
| 84 | RET | 0.64974679 |
| 85 | SGK3 | 0.62856418 |
| 86 | MAP3K13 | 0.62430571 |
| 87 | GRK7 | 0.61003349 |
| 88 | CSNK1A1L | 0.59949878 |
| 89 | ERBB3 | 0.58808126 |
| 90 | RIPK4 | 0.57874893 |
| 91 | CAMK4 | 0.57465233 |
| 92 | CSNK1G3 | 0.57406786 |
| 93 | RPS6KB1 | 0.57004046 |
| 94 | DAPK1 | 0.56200960 |
| 95 | MAPK10 | 0.55824749 |
| 96 | TAOK1 | 0.54406699 |
| 97 | TNK2 | 0.54404766 |
| 98 | MAPK4 | 0.54089404 |
| 99 | ADRBK1 | 0.53982870 |
| 100 | RPS6KA3 | 0.53286489 |
| 101 | CSF1R | 0.52668432 |
| 102 | PRKCE | 0.52099840 |
| 103 | FGFR2 | 0.51958902 |
| 104 | ARAF | 0.51888911 |
| 105 | PRKCZ | 0.51325474 |
| 106 | PRKG1 | 0.50515665 |
| 107 | MAPK7 | 0.50493761 |
| 108 | BMX | 0.50284022 |
| 109 | ROCK1 | 0.49946292 |
| 110 | MAPKAPK5 | 0.49927148 |
| 111 | MAP2K1 | 0.48125473 |
| 112 | IRAK2 | 0.47407034 |
| 113 | MAP2K3 | 0.46874171 |
| 114 | FYN | 0.45560982 |
| 115 | PDPK1 | 0.45094921 |
| 116 | WNK3 | 0.44990662 |
| 117 | PDK1 | 0.44831787 |
| 118 | LATS2 | 0.43531833 |
| 119 | DYRK1B | 0.42319465 |
| 120 | TIE1 | 0.40790401 |
| 121 | PRKACA | 0.35107793 |
| 122 | MAP2K6 | 0.33855559 |
| 123 | EPHB2 | 0.33186297 |
| 124 | PRKCQ | 0.32796539 |
| 125 | VRK1 | 0.32185370 |
| 126 | PRKAA1 | 0.30094364 |
| 127 | RAF1 | 0.30042732 |
| 128 | MAPK8 | 0.29987365 |
| 129 | PTK2B | 0.29182586 |
| 130 | GSK3B | 0.29007344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 4.82790275 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.29280187 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.91916178 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.78904304 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.49548388 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.43939712 |
| 7 | * Olfactory transduction_Homo sapiens_hsa04740 | 2.42215601 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.40021316 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.32183555 |
| 10 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.04130051 |
| 11 | Platelet activation_Homo sapiens_hsa04611 | 2.00242222 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.98328773 |
| 13 | Long-term potentiation_Homo sapiens_hsa04720 | 1.96977163 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.92302857 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.85614182 |
| 16 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.82079859 |
| 17 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.76152436 |
| 18 | Insulin secretion_Homo sapiens_hsa04911 | 1.71954287 |
| 19 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.68813686 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.65234190 |
| 21 | Cocaine addiction_Homo sapiens_hsa05030 | 1.64574631 |
| 22 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.63196847 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.61882955 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.54382733 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.53032100 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.52596064 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.50367967 |
| 28 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.43069694 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.37049416 |
| 30 | Axon guidance_Homo sapiens_hsa04360 | 1.27804806 |
| 31 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.25143242 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.22604716 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.21162456 |
| 34 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.17713542 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.15922221 |
| 36 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.14720279 |
| 37 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13697427 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.13587111 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.11449112 |
| 40 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.10713620 |
| 41 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.07146923 |
| 42 | * cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02906857 |
| 43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.99367441 |
| 44 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.98367224 |
| 45 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.97503687 |
| 46 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.91623721 |
| 47 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.90169337 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.89808445 |
| 49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.89552699 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88769321 |
| 51 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.87820942 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 0.84722487 |
| 53 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82240521 |
| 54 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.81631888 |
| 55 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.79579379 |
| 56 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77301479 |
| 57 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.73966094 |
| 58 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.73736546 |
| 59 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.73590380 |
| 60 | Glioma_Homo sapiens_hsa05214 | 0.72711241 |
| 61 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72372262 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72154984 |
| 63 | Alzheimers disease_Homo sapiens_hsa05010 | 0.71958096 |
| 64 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70041973 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.69181863 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.66572881 |
| 67 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65382657 |
| 68 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.63254147 |
| 69 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.63043918 |
| 70 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62062704 |
| 71 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.61621621 |
| 72 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.61329251 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.59639332 |
| 74 | Endometrial cancer_Homo sapiens_hsa05213 | 0.58894826 |
| 75 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56759108 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56607620 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.55811274 |
| 78 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55632294 |
| 79 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55575782 |
| 80 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.52960656 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.52800454 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52712470 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52590414 |
| 84 | Alcoholism_Homo sapiens_hsa05034 | 0.52454677 |
| 85 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51812158 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51633516 |
| 87 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.51526020 |
| 88 | Tight junction_Homo sapiens_hsa04530 | 0.47957955 |
| 89 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.46985038 |
| 90 | Focal adhesion_Homo sapiens_hsa04510 | 0.46378778 |
| 91 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46322933 |
| 92 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.46004204 |
| 93 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.45349302 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43760137 |
| 95 | Endocytosis_Homo sapiens_hsa04144 | 0.43601732 |
| 96 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.43268909 |
| 97 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.43047598 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42502254 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39991985 |
| 100 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.38068675 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37776406 |
| 102 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37293300 |
| 103 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.36852402 |
| 104 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.36679161 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.36549049 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.36513886 |
| 107 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36494449 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35875641 |
| 109 | Bile secretion_Homo sapiens_hsa04976 | 0.34706485 |
| 110 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34672418 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34431275 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.34430604 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.33700553 |
| 114 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33606278 |
| 115 | Asthma_Homo sapiens_hsa05310 | 0.33578754 |
| 116 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.33229873 |
| 117 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.32882782 |
| 118 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32810690 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.32342078 |
| 120 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32327318 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.31619582 |
| 122 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.31537821 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.28220783 |

